Replies to post #438205 on Amarin Corp Plc (AMRN)

[couldbebetter]

Obviously Alex Denner did not expect the share price of AMRN
to fall to the levels it did, so whatever he may have had in mind
did not work out, at least as initially planned. Also, it took a
long time for Denner to figure out that having AMRN build a
sales force for Europe was impractical. I certainly hope that
SDL is correct in his supposition that NVS will acquire AMRN.
At some point I hope we get some details on the new formulation
and exactly what AMRN plans to do with it. Will they use it as
a platform drug? Will they attempt to get it approved for new
indications? Will they use it as bait for a BP BO? Before I get
excited about any of this I hope too see the share price surge
much higher.
I

[Liz40]

A couple of years ago I heard a radio program with female partner of Denner discussing his strategy. Buy a company with a current patent plus fda approval. Reformulate to extend patent life.